Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

[Genetics factors determining predisposition to chronic course of virus hepatitis and fibrosis in liver].

Goncharova IA, Beloborodova EV, Freĭdin MB, Beloborodova EI, Chernogoriuk GE, Puzyrev VP.

Mol Biol (Mosk). 2008 Mar-Apr;42(2):238-41. Russian.

PMID:
18610831
2.

[Association study of the Ile50Val polymorphism of interleukin-4 receptor gene (IL4RA) with chronic viral hepatitis].

Goncharova IA, Freĭdin MB, Dunaeva LE, Beloborodova EV, Beloborodova EV, Puzyrev VP.

Mol Biol (Mosk). 2005 May-Jun;39(3):379-84. Russian.

PMID:
15981567
3.

Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus.

Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK.

J Med Virol. 2004 Jan;72(1):60-5. Erratum in: J Med Virol. 2004 Mar;72(3):509.

PMID:
14635012
4.

Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C.

Bahr MJ, el Menuawy M, Boeker KH, Musholt PB, Manns MP, Lichtinghagen R.

Liver Int. 2003 Dec;23(6):420-5.

PMID:
14986816
5.

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.

Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ.

Genes Immun. 2000 Aug;1(6):386-90.

6.

[Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients].

Li Z, Li HQ, Yan Y, Liu Y, Hao W, Niu JQ, Yin JM, Li H.

Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2105-8. Chinese.

PMID:
17988528
7.

Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

Halangk J, Sarrazin C, Neumann K, Puhl G, Mueller T, Teuber G, Klinker H, Hinrichsen H, Buggisch P, Landt O, Weich V, Bergk A, Wiedenmann B, Neuhaus P, Berg T, Witt H.

J Hepatol. 2008 Sep;49(3):339-45. doi: 10.1016/j.jhep.2008.05.021. Epub 2008 Jun 23.

PMID:
18644651
8.

[Association of immune system gene polymorphisms with quantitative features which are pathogenetically important in chronic viral hepatitis].

Goncharova IA, Beloborodova EV, Freĭdin MB, Beloborodova EI, pyzurev VP.

Mol Biol (Mosk). 2008 Mar-Apr;42(2):242-6. Russian.

PMID:
18610832
9.

Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.

Falleti E, Cmet S, Fabris C, Bitetto D, Cussigh A, Fornasiere E, Bignulin E, Feruglio C, Mosanghini E, Fontanini E, Pirisi M, Toniutto P.

Cytokine. 2012 Jan;57(1):68-73. doi: 10.1016/j.cyto.2011.10.018. Epub 2011 Nov 27.

PMID:
22122913
10.

Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey.

Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B.

Infect Genet Evol. 2008 Jan;8(1):20-5. Epub 2007 Sep 14.

PMID:
17974504
11.

[IMMUNOGENETICS AND PROGRESSION OF CHRONIC VIRAL HEPATITES].

Beloborodova EV, Goncharova IA, Beloborodova EI, Purlik IL, Kalacheva TP, Akbasheva OE, Rachkovskiy MI, Burkovskaya VA.

Eksp Klin Gastroenterol. 2015;(3):45-9. Russian.

PMID:
26281177
12.

[Genetic risk factors for hepatic fibrosis in chronic liver diseases].

Wasmuth HE, Lammert F, Matern S.

Med Klin (Munich). 2003 Dec 15;98(12):754-62. Review. German.

PMID:
14685677
13.

Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.

Dai CY, Chuang WL, Hsieh MY, Lee LP, Hou NJ, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.

Transl Res. 2006 Sep;148(3):128-33.

PMID:
16938650
14.

Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.

Sermasathanasawadi R, Kato N, Muroyama R, Dharel N, Shao RX, Chang JH, Li CZ, Kawabe T, Omata M.

Liver Int. 2008 Jul;28(6):798-806. doi: 10.1111/j.1478-3231.2008.01725.x.

PMID:
18397234
15.

Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection.

Papatheodoridis GV, Paraskevis D.

Liver Int. 2008 Jul;28(6):764-6. doi: 10.1111/j.1478-3231.2008.01800.x. No abstract available.

PMID:
18647140
16.

Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease.

Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, Hissar S.

J Hepatol. 2006 May;44(5):856-63. Epub 2006 Feb 21.

PMID:
16545485
17.

[Polymorphism and liver fibrosis].

Guo JS.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):565-7. Chinese. No abstract available.

PMID:
23227529
18.

Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.

Fishman S, Lurie Y, Peretz H, Morad T, Grynberg E, Blendis LM, Leshno M, Brazowski E, Rosner G, Halpern Z, Oren R.

Liver Int. 2006 Apr;26(3):279-84.

PMID:
16584388
19.

Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.

Schott E, Witt H, Pascu M, van Boemmel F, Weich V, Bergk A, Halangk J, Müller T, Puhl G, Wiedenmann B, Berg T.

Eur J Gastroenterol Hepatol. 2007 Nov;19(11):947-51.

PMID:
18049163
20.

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Ross D, Hu X, Monto A, McAllister LB, Broder S, White T, Sninsky JJ, Wright TL.

Gastroenterology. 2006 May;130(6):1679-87. Epub 2006 Mar 6.

PMID:
16697732

Supplemental Content

Support Center